Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial–mesenchymal transition
Cited by 103
Related Papers
Metabolomic analyses reveal new stage-specific features of COVID-19
|European Respiratory Journal|2021|112
TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration
|Frontiers in Immunology|2021|75
EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3
|Cell Death and Disease|2020|33